Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

BackgroundDiagnosing immune checkpoint inhibitor (ICI)-associated nephritis can be challenging since it is a rare complication of therapy, associated with a spectrum of immune-mediated pathologies, and can present months after ICI therapy discontinuation (i.e., late-onset). ICIs are increasingly adm...

Full description

Bibliographic Details
Main Authors: Praveen Ratanasrimetha, Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel, Jamie S. Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor (ICI)
immune related adverse events (irAEs)
membranous nephropathy (MN)
proteinuria
rituximab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.898811/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.898811/full

Similar Items